The government has announced the postponement of the program to introduce AstraZeneca Vaccine in people of this age group.
Symbolic picture
Canada Stopped Use of COVID AstraZeneca Vaccine: The Oxford AstraZeneca vaccine (Oxford AstraZeneca Vaccine) formulated against the Coronavirus has been in constant controversy for some time. Despite the company’s statement and new figures, this dispute is not diminishing. Now the Canadian government has prohibited the introduction of this vaccine developed by Oxford AstraZeneca to people under 55 years old. The government has taken this decision in view of the possibility of a rare case of blood clotting in the people of this age due to vaccine.
Announcing the postponement of the AstraZeneca vaccine program for people in this age group, the National Advisory Committee on Vaccination in Canada advised to stop vaccinations for safety reasons (AstraZeneca Vaccine Ban in Europe) . Dr. Shelley Dick, Chairperson of the National Advisory Committee on Vaccination, said, “There is a lot of uncertainty about its benefits against the potential danger of giving the vaccine to AstraZeneca to people under 55 years of age.”
Why did the government stop?
The DIN recommends this among data from Europe, which suggests that blood clots from the vaccine are likely to occur in one in every one million cases, far exceeding the prediction of one event per million in the past (AstraZeneca Vaccine Efficacy). He said that those who took AstraZeneca vaccine in Europe who complained of blood clotting (AstraZeneca Vaccine and Blood Clots), most of them are women below 55 years and have a mortality rate of 40 percent. This is the reason why the government has banned the vaccine.
What did the company say?
When several European countries prohibited the use of the vaccine, AstraZeneca issued a statement saying that it had carefully reviewed the figures of 1.70 million people in Europe. The company had said, “No evidence has been found in any country of the world, in any gender or in any age group, which suggests the danger of blood clotting.” This vaccine has been developed jointly by Oxford University of Britain and pharmaceutical company AstraZeneca (AstraZeneca Vaccine Belongs to Which Country). At the same time, in India, Pune-based company is manufacturing this vaccine under the Serum Institute of India license.
Also read- Within a year, the world will need a new vaccine, scientists say the reason
Also read- Thailand denied reports of repatriation of people who fled from Myanmar, saying – we are ready to give asylum
.